Global Transdermal Drug Delivery System Market, By Type (Transdermal Patches, Transdermal Semisolids), Application (Pain Management, Hormonal Applications, Central Nervous System Disorders, Cardiovascular Diseases, Smoking Cessation, Contraception, Other Applications), End User (Home Care Settings, Hospitals and Clinics), Technology (Electroporation, Electric current, Lontophoresis, Radio Frequency, Microporation, Thermal, Mechanical arrays, Ultrasound, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Transdermal drug delivery system market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 6,965.49 million by 2028 growing at a CAGR of 4.39% in the above-mentioned forecast period. The growing awareness amongst the physicians and patients regarding the benefits of transdermal drug delivery system which will further create lucrative opportunities for the growth of the market.
Transdermal drug delivery provides a range of benefits over other drug delivery systems, such as improved efficacy-to-tolerability ratio by monitoring serum drug levels, regulated and sustained drug release, and preventing pre-systemic gastrointestinal and hepatic metabolism. Transdermal drug delivery systems such as patches find their key use to diabetic patients in the delivery of insulin.
Surging volume of patients suffering from chronic disorders across the globe, increasing prevalence of geriatric population worldwide, rising adoption of third-generation delivery systems, growing spending on healthcare by the population, increasing consumption of transdermal drug delivery patch, rise in demand for improved and technologically advanced drugs and devices are some of the major as well as vital factors which will likely to augment the growth of the transdermal drug delivery system market in the projected timeframe of 2021-2028. On the other hand, self-administration and home care drug delivery systems along with increasing collaborations between pharmaceutical companies and drug delivery firms which will further contribute by generating massive opportunities for the growth of the transdermal drug delivery system market in the above mentioned projected timeframe.
Drug failure and recalls of transdermal drug delivery systems along with side effects of the system which will likely to act as market restraints factor for the growth of the transdermal drug delivery system in the above mentioned projected timeframe. Technical barriers related to skin irritation and permeability which will become the biggest and foremost challenge for the growth of the market.
This transdermal drug delivery system market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on transdermal drug delivery system market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Transdermal Drug Delivery System Market Scope and Market Size
Transdermal drug delivery system market is segmented on the basis of type, application, technology and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on type, the transdermal drug delivery system market is segmented into transdermal patches, and transdermal semisolids. Transdermal patches have been further segmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and microneedle patches. Transdermal semisolids have been further segmented into gels, ointments, and sprays.
- Transdermal drug delivery system market has also been segmented based on the end user into home care settings, hospitals and clinics.
- Based on application, the transdermal drug delivery system market is segmented into pain management, hormonal applications, central nervous system disorders, cardiovascular diseases, smoking cessation, contraception, and other applications. Hormonal applications have been further segmented into testosterone replacement therapy, and transdermal estrogen therapy.
- On the basis of technology, the transdermal drug delivery system market is segmented into electroporation, electric current, lontophoresis, radio frequency, microporation, thermal, mechanical arrays, ultrasound, and others.
Transdermal Drug Delivery System Market Country Level Analysis
Transdermal drug delivery system market is analysed and market size insights and trends are provided by country, type, application, technology and end user as referenced above.
The countries covered in the transdermal drug delivery system market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the transdermal drug delivery system market due to the surging levels of investment by the market players along with rising prevalence of targeted diseases such as chronic pain, central nervous system disorders, and cardiovascular diseases, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2021 to 2028 due to the improvement in the healthcare infrastructure along with growing number of research and development activities in the region.
The country section of the transdermal drug delivery system market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Transdermal drug delivery system market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for transdermal drug delivery system market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the transdermal drug delivery system market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Transdermal Drug Delivery System Market Share Analysis
Transdermal drug delivery system market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to transdermal drug delivery system market.
The major players covered in the transdermal drug delivery system market report are Hisamitsu Pharmaceutical Co.,Inc.; Mylan Pharmaceuticals ULC.; UCB S.A.; Novartis AG; GlaxoSmithKline plc.; Boehringer Ingelheim International GmbH; Johnson & Johnson Services, Inc.; Endo International plc; Purdue Pharma Manufacturing L.P.; Lavipharm.; LEAD CHEMICAL Co.,Ltd.; Luye Pharma Group; Allergan.; IBSA Farmaceutici Italia Srl; Pfizer Inc.; TEH SENG PHARMACEUTICAL MFG. CO., LTD.; Teikoku Seiyaku Co.,Ltd.; 3M; Janssen Global Services, LLC; Bayer AG; among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Transdermal Drug Delivery System Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.